JP2021527638A5 - - Google Patents
Info
- Publication number
- JP2021527638A5 JP2021527638A5 JP2020568282A JP2020568282A JP2021527638A5 JP 2021527638 A5 JP2021527638 A5 JP 2021527638A5 JP 2020568282 A JP2020568282 A JP 2020568282A JP 2020568282 A JP2020568282 A JP 2020568282A JP 2021527638 A5 JP2021527638 A5 JP 2021527638A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- heterocycloalkyl
- heteroaryl
- aryl
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862683557P | 2018-06-11 | 2018-06-11 | |
| US62/683,557 | 2018-06-11 | ||
| US201962832734P | 2019-04-11 | 2019-04-11 | |
| US62/832,734 | 2019-04-11 | ||
| PCT/US2019/036611 WO2019241292A1 (en) | 2018-06-11 | 2019-06-11 | Hepatitis b capsid assembly modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021527638A JP2021527638A (ja) | 2021-10-14 |
| JP2021527638A5 true JP2021527638A5 (https=) | 2022-06-17 |
| JPWO2019241292A5 JPWO2019241292A5 (https=) | 2022-06-17 |
Family
ID=68765513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568282A Pending JP2021527638A (ja) | 2018-06-11 | 2019-06-11 | Ｂ型肝炎カプシドアセンブリモジュレーター |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US10590076B2 (https=) |
| EP (1) | EP3807246A4 (https=) |
| JP (1) | JP2021527638A (https=) |
| KR (1) | KR20210019489A (https=) |
| CN (1) | CN112585118A (https=) |
| AU (1) | AU2019284617A1 (https=) |
| BR (1) | BR112020025073A2 (https=) |
| CA (1) | CA3102972A1 (https=) |
| DE (1) | DE202019005471U1 (https=) |
| GB (1) | GB2583614B (https=) |
| IL (1) | IL279242A (https=) |
| PH (1) | PH12020552127A1 (https=) |
| SG (1) | SG11202012346YA (https=) |
| TW (1) | TW202016073A (https=) |
| WO (1) | WO2019241292A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2943204B1 (en) | 2013-01-10 | 2019-03-13 | Venatorx Pharmaceuticals Inc | Beta-lactamase inhibitors |
| WO2015191907A1 (en) | 2014-06-11 | 2015-12-17 | VenatoRx Pharmaceuticals, Inc. | Beta-lactamase inhibitors |
| WO2019118358A1 (en) | 2017-12-11 | 2019-06-20 | VenatoRx Pharmaceuticals, Inc. | Hepatitis b capsid assembly modulators |
| CN115974753A (zh) * | 2018-03-30 | 2023-04-18 | 正大天晴药业集团股份有限公司 | 含有n杂五元环化合物和用途 |
| KR102752886B1 (ko) * | 2018-05-25 | 2025-01-09 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | 2,3-디히드로-1h-피롤리진-7-포름아미드 유도체 및 그 사용 |
| DE202019005471U1 (de) | 2018-06-11 | 2020-09-17 | VenatoRx Pharmaceuticals, Inc. | Hepatitis B Kapsid-Assemblierungsmodulatoren |
| BR112021006403A2 (pt) * | 2018-10-05 | 2021-07-06 | Univ Emory | agentes monômeros e multiméricos anti-hbv |
| EA202092159A1 (ru) * | 2019-01-25 | 2020-12-15 | Чиа Тай Тянцин Фармасьютикал Груп Ко., Лтд. | Содержащий n-гетероциклическое пятичленное кольцо ингибитор сборки капсидного белка, его фармацевтическая композиция и их применение |
| WO2020156494A1 (zh) * | 2019-01-31 | 2020-08-06 | 正大天晴药业集团股份有限公司 | 含有吡咯并杂环的衣壳蛋白装配抑制剂 |
| ES3064043T3 (en) | 2019-09-29 | 2026-04-22 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | Crystalline forms of a capsid protein assembly inhibitor containing a pyrrole ring, and application thereof |
| WO2021058001A1 (zh) | 2019-09-29 | 2021-04-01 | 正大天晴药业集团股份有限公司 | N杂五元环化合物的晶型及其应用 |
| AU2020385034B2 (en) * | 2019-11-13 | 2024-11-14 | Xi'an Xintong Pharmaceutical Research Co., Ltd. | HBV inhibitor and use thereof |
| WO2021119081A1 (en) * | 2019-12-10 | 2021-06-17 | VenatoRx Pharmaceuticals, Inc. | Hepatitis b capsid assembly modulators |
| WO2021178362A1 (en) * | 2020-03-03 | 2021-09-10 | VenatoRx Pharmaceuticals, Inc. | Hepatitis b capsid assembly modulators |
| WO2021197486A1 (zh) * | 2020-04-03 | 2021-10-07 | 东莞市东阳光新药研发有限公司 | 新型螺环类化合物及其在药物中的应用 |
| JP2024537830A (ja) | 2021-10-08 | 2024-10-16 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド | カプシドタンパク質阻害剤と逆転写酵素阻害剤とを含む医薬組合せ |
| WO2024149314A1 (zh) * | 2023-01-12 | 2024-07-18 | 成都微芯药业有限公司 | 氨基噻吩类化合物、其制备方法及用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1059007A (en) | 1912-05-21 | 1913-04-15 | Benjamin F Sharp | Electrical burglar-alarm. |
| JP2005060379A (ja) * | 2003-07-31 | 2005-03-10 | Dainippon Pharmaceut Co Ltd | 複素環式化合物からなる医薬 |
| US20080318922A1 (en) | 2004-12-24 | 2008-12-25 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic Pyrrole Derivatives |
| CA2635209A1 (en) | 2006-01-12 | 2007-08-02 | Merck & Co., Inc. | Fluorinated arylamide derivatives |
| EP3085368A1 (en) * | 2011-07-01 | 2016-10-26 | Baruch S. Blumberg Institute | Sulfamoylbenzamide derivatives as antiviral agents against hbv infection |
| WO2013096744A1 (en) | 2011-12-21 | 2013-06-27 | Novira Therapeutics, Inc. | Hepatitis b antiviral agents |
| DK3024819T3 (en) * | 2013-07-25 | 2018-06-06 | Janssen Sciences Ireland Uc | GLYOXAMIDE-SUBSTITUTED PYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR TREATING HEPATITIS B |
| KR102290189B1 (ko) * | 2013-10-23 | 2021-08-17 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 카르복스아미드 유도체 및 ｂ형 간염 치료용 의약으로서의 이의 용도 |
| WO2015118057A1 (en) | 2014-02-06 | 2015-08-13 | Janssen Sciences Ireland Uc | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
| US10875876B2 (en) | 2015-07-02 | 2020-12-29 | Janssen Sciences Ireland Uc | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
| US10752584B2 (en) * | 2016-03-09 | 2020-08-25 | Emory University | Elimination of hepatitis B virus with antiviral agents |
| JOP20190024A1 (ar) * | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
| CN108250121A (zh) * | 2016-12-28 | 2018-07-06 | 上海长森药业有限公司 | 磺酰胺-芳基酰胺类化合物及其治疗乙型肝炎的药物用途 |
| WO2019118358A1 (en) | 2017-12-11 | 2019-06-20 | VenatoRx Pharmaceuticals, Inc. | Hepatitis b capsid assembly modulators |
| PL3759109T3 (pl) | 2018-02-26 | 2024-03-04 | Gilead Sciences, Inc. | Podstawione związki pirolizyny jako inhibitory replikacji hbv |
| CN115974753A (zh) | 2018-03-30 | 2023-04-18 | 正大天晴药业集团股份有限公司 | 含有n杂五元环化合物和用途 |
| KR102752886B1 (ko) | 2018-05-25 | 2025-01-09 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | 2,3-디히드로-1h-피롤리진-7-포름아미드 유도체 및 그 사용 |
| DE202019005471U1 (de) | 2018-06-11 | 2020-09-17 | VenatoRx Pharmaceuticals, Inc. | Hepatitis B Kapsid-Assemblierungsmodulatoren |
| WO2020156494A1 (zh) | 2019-01-31 | 2020-08-06 | 正大天晴药业集团股份有限公司 | 含有吡咯并杂环的衣壳蛋白装配抑制剂 |
| ES3064043T3 (en) | 2019-09-29 | 2026-04-22 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | Crystalline forms of a capsid protein assembly inhibitor containing a pyrrole ring, and application thereof |
| WO2021058001A1 (zh) | 2019-09-29 | 2021-04-01 | 正大天晴药业集团股份有限公司 | N杂五元环化合物的晶型及其应用 |
| US20230026869A1 (en) | 2019-11-22 | 2023-01-26 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Crystal form of nucleoprotein inhibitor and use thereof |
| WO2021119081A1 (en) | 2019-12-10 | 2021-06-17 | VenatoRx Pharmaceuticals, Inc. | Hepatitis b capsid assembly modulators |
| WO2021178362A1 (en) | 2020-03-03 | 2021-09-10 | VenatoRx Pharmaceuticals, Inc. | Hepatitis b capsid assembly modulators |
| EP4241770A1 (en) | 2020-11-05 | 2023-09-13 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Pharmaceutical combination containing capsid protein inhibitor and nucleoside analog |
-
2019
- 2019-06-11 DE DE202019005471.5U patent/DE202019005471U1/de active Active
- 2019-06-11 BR BR112020025073-2A patent/BR112020025073A2/pt not_active Application Discontinuation
- 2019-06-11 GB GB2010185.3A patent/GB2583614B/en active Active
- 2019-06-11 SG SG11202012346YA patent/SG11202012346YA/en unknown
- 2019-06-11 CA CA3102972A patent/CA3102972A1/en active Pending
- 2019-06-11 KR KR1020217000251A patent/KR20210019489A/ko not_active Ceased
- 2019-06-11 WO PCT/US2019/036611 patent/WO2019241292A1/en not_active Ceased
- 2019-06-11 AU AU2019284617A patent/AU2019284617A1/en not_active Abandoned
- 2019-06-11 EP EP19819142.1A patent/EP3807246A4/en not_active Withdrawn
- 2019-06-11 CN CN201980054009.1A patent/CN112585118A/zh active Pending
- 2019-06-11 TW TW108120145A patent/TW202016073A/zh unknown
- 2019-06-11 US US16/438,361 patent/US10590076B2/en active Active
- 2019-06-11 JP JP2020568282A patent/JP2021527638A/ja active Pending
- 2019-11-01 US US16/671,815 patent/US11014881B2/en not_active Expired - Fee Related
-
2020
- 2020-12-06 IL IL279242A patent/IL279242A/en unknown
- 2020-12-10 PH PH12020552127A patent/PH12020552127A1/en unknown
-
2021
- 2021-10-29 US US17/514,578 patent/US11566001B2/en active Active
-
2022
- 2022-09-19 US US17/947,593 patent/US20230062975A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527638A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2012526728A5 (https=) | ||
| JP2020532547A5 (https=) | ||
| JP2014511891A5 (https=) | ||
| JP2018507877A5 (https=) | ||
| JP2021513534A5 (https=) | ||
| JPWO2019241292A5 (https=) | ||
| JP2010523522A5 (https=) | ||
| JP2021514001A5 (https=) | ||
| JP2017526677A5 (https=) | ||
| JPWO2022251502A5 (https=) | ||
| JP2014511892A5 (https=) | ||
| JP2020502092A5 (https=) | ||
| JP2018529650A5 (https=) | ||
| RU2017111200A (ru) | Циклогексилэтилзамещенные диаза- и триаза-трициклические соединения в качестве антагонистов индоламин-2,3-диоксигеназы для лечения рака | |
| JP2011509309A5 (https=) | ||
| JP2017524025A5 (https=) | ||
| JP2013502431A5 (https=) | ||
| JP2021512098A5 (https=) | ||
| JP2017523169A5 (https=) | ||
| JP2021512109A5 (https=) | ||
| JP2020507566A5 (https=) | ||
| JP2017519754A5 (https=) | ||
| JP2006507220A5 (https=) |